ConductScience.org, home

Paper10450985

Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.

Laurin P and 7 others. Bioorg Med Chem Lett, 1999. Cited by 90 papers, by iCite.

Cite this record

ConductScience Library. Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B. Papers, record 10450985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10450985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
PubMed
Journal
Bioorg Med Chem Lett
PubMed
Year
1999
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
90
iCite
Relative citation ratio, by iCite
2.87
iCite
Revised in PubMed
2019-08-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Laurin PP
2Ferroud DD
3Klich MM
4Dupuis-Hamelin CC
5Mauvais PP
6Lassaigne PP
7Bonnefoy AA
8Musicki BB

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CoumarinsMajor topic
Enzyme InhibitorsMajor topic
Topoisomerase II InhibitorsMajor topic
Anti-Bacterial Agents
DNA Gyrase
Drug Design
Enterococcus
Escherichia coli
Inhibitory Concentration 50
Methicillin Resistance
Microbial Sensitivity Tests
Novobiocin
Staphylococcus
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.

PMIDTitleJournalYearIn PapersSource
41032102Choline hydroxide mediated eco-friendly synthesis of 5-arylidene thiazol-4(5H)-one clubbed coumarin: antimicrobial evaluation and in silico studies.Naturwissenschaften2025https://conductscience.org/library/papers/41032102PubMed
34640121The Synthesis and Evaluation of Aminocoumarin Peptidomimetics as Cytotoxic Agents on Model Bacterial E. coli Strains.Materials (Basel)2021https://conductscience.org/library/papers/34640121PubMed
32486298Coumarin Derivatives as New Toxic Compounds to Selected K12, R1-R4 E. coli Strains.Materials (Basel)2020https://conductscience.org/library/papers/32486298PubMed
28634338Coumarin-benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation.J Antibiot (Tokyo)2017https://conductscience.org/library/papers/28634338PubMed
28496477Cytotoxic Properties of Three Isolated Coumarin-hemiterpene Ether Derivatives from Artemisia armeniaca Lam.Iran J Pharm Res2017https://conductscience.org/library/papers/28496477PubMed
28262031Antifungal and antioxidant activities of Coleonema album and C. pulchellum against skin diseases.Pharm Biol2017https://conductscience.org/library/papers/28262031PubMed
23819586New dicoumarol sodium compound: crystal structure, theoretical study and tumoricidal activity against osteoblast cancer cells.Chem Cent J2013https://conductscience.org/library/papers/23819586PubMed
23587363Synthesis, characterization, in vitro antimicrobial, and U2OS tumoricidal activities of different coumarin derivatives.Chem Cent J2013https://conductscience.org/library/papers/23587363PubMed
23348993Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents.Molecules2013https://conductscience.org/library/papers/23348993PubMed
22749529Sequential posttranslational modifications program FEN1 degradation during cell-cycle progression.Mol Cell2012https://conductscience.org/library/papers/22749529PubMed
18347114Biological activities of novel gyrase inhibitors of the aminocoumarin class.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18347114PubMed
18274603New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin-3-Carboxylic Acid as Antiproliferative Agents.Met Based Drugs2007https://conductscience.org/library/papers/18274603PubMed
16569821Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16569821PubMed
15218104Mass spectrometric characterization of a three-enzyme tandem reaction for assembly and modification of the novobiocin skeleton.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15218104PubMed
15047534Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15047534PubMed
11036020Identification of the coumermycin A(1) biosynthetic gene cluster of Streptomyces rishiriensis DSM 40489.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/11036020PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TOP2A7153PubTator's text mininghttps://conductscience.org/library/genes/7153

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10450985

GET https://conductscience.org/api/papers/v1/10450985/authors